Influence of Epilobium angustifolium extract on 5α-reductase and MAPK3 kinase gene expression in rats prostates Vol. 59 No. 4 2013 S u m m a r y The aim of this study was to investigate the influence of standardized Epilobium angustifolium L. extract [100 mg/kg/day, p.o.] on the expression level of 5α-reductase type 2 (Srd5ar2) mRNA and Mapk3 mRNA a representative of non-genomic xenobiotics signaling pathway. It was shown that plant extract from the E. angustifolium showed a slight tendency to reduce prostate weight in hormonally induced animals (p>0.05) and in testosterone induced animals receiving both, extract and finasteride (p<0.05). Finasteride in rats induced by testosterone caused a smaller decrease in the level of mRNA 5α-steroid reductase 2 (SRd5ar2), than in rats treated with the hormone and studied plant extracts. In general, an increase in the amount of MaPK3 mRNAs in testosterone-induced groups of rats receiving tested plant extract with or without finasteride was observed, while the expression of type 2 5α-steroid reductase decreased (p<0.05). Further experimental studies should be performed in order to understand the molecular basis of interactions, the efficacy and safety of tested plant extracts.
INTRODuCTION
Benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) associated with these disease are very serious health and socio-economic problems of modern society. Due to numerous side effects, in consequence of BPH/ LUTS long-term pharmacotherapy [1, 2] , there is a growing interest in searching for alternative forms of therapy, in particular with use of preparations of plant plant origin [3] [4] [5] [6] .
One of herbal materials traditionally used in form of infusions in case of prevention and complementary treatment in early stages of benign prostatic hyperplasia (BPH) are Epilobium sp. representatives [6] [7] [8] [9] . The most popular European species of this genus are species as follows: E. angustifolium L., E. parviflorum Schreb. and E. hirsutum L. [9] [10] [11] [12] . Individual members of the Epilobium genus and extracts obtained from these plants are very well phytochemicaly characterized [6, [11] [12] [13] [14] [15] . The vast majority of studies highlightes an antiproliferative, antiinflammatory and antioxidant potential of Epilobium sp. representatives [16] [17] [18] [19] [20] [21] [22] [23] . The influence of Epilobium sp. various extracts, fractions and their bioactive metabolites on androgen/estrogen-related enzymes and apoptosis pathways proteins, i.e. 5α-steroid reductase and aromatase [24] [25] , caspase 3 [11] , estrogen receptors [26] and several metaloproteinases activities [14, 27] has been described previously. These and other androgen-dependent proteins, usually directly related to the activity of the androgen receptor (AR), belong to so-called genomics signaling pathway [28] [29] . However, the molecular mechanism of action of any Epilobium sp. preparations, their bio-active metabolites on the activity of the genes or proteins involved in a second one, a non-genomic signaling pathway of steroid hormones in prostate gland cells is still not known, in particular in a model organism. This cellular signaling pathway is characterized by speed indicating a lack of transcription and translation from androgen-responsive genes [29] [30] [31] [32] . In this signaling cascade a number of protein kinases are involved, including MaPK (ERK1/2) kinases (in rats: MaPK3/ MaPK1, respectively) [28] [29] [33] [34] .
In this study, an attempt was made to assess the impact of a crude aqueous extract from Epilobium angustifolium leaves on 5α-reductase type 2 mRNA (SRd5ar2 -a prostate enzyme isoform crucial for the BPH development, generating dihydrotestosterone from the testosterone) [35] [36] [37] and MAPK3 kinase mRNA (a representative of one of the non-genomic cellular signal transduction proteins) [33] [34] in testosterone-induced rats prostate ventral lobes. Subsequently, observed expression changes were compared with changes in rats prostates weight. Understanding the molecular basis of interactions caused by tested plant extracts in a rat model of hormone-induced prostatic hyperplasia may, in the longer period, significantly contribute to the establishment of their effective and safe doses in the prevention and symptomatic treatment of BPH.
MATERIAL AND METhODS

Plant extract preparation
Standardized dried aqueous extract from of Epilobium angustifolium herb (0.91% m/m flavonoglycoside compounds expressed as quercetin, 24.36% m/m phenolic compounds expressed as gallic acid, 0.09% m/m sterol compounds expressed as β-sitosterol and 0.01% m/m tannin compounds expressed as pyrogallol) was obtained from the Institute of Natural Fibers and Medicinal Plants, Poznań, Poland).
Animals treatment
Adult male four-week-old Wistar rats (180-250 g) were housed in plastic cages at the Department of Pharmacology, Poznan University of Medical Sciences. Animals were kept in a climate-controlled room with twelve-hour light/dark cycle and allowed the access to commercial rat chow and tap water ad libitum. They were acclimatized for at least a few days prior to experiment. All rats were divided by randomization into 7 groups (each group consisted of 10 animals). All substances were administered for 21 consecutive days.
The control group (control for finasteride-treated animals) was treated with an arachidonic oil with dimethyl sulfoxide (DMSO) [ . Following four groups of rats were testosterone-induced in order to increase prostate mass. Induced control rats received a testosterone (Testosteronum prolongatum, 100 mg/ml, Jelfa; 40mg/kg/day, 3 times, each 7th day; s.c). dissolved in arachidonic oil [38] . A "mixed" group of rats represented a combined treatment with testosterone (Testosteronum prolongatum 100 mg/ml, Jelfa; 40mg/kg/day, 3 times, each 7th day; s.c.) dissolved in arachidonic oil and dried water extract of Epilobium angustifolium [100 mg/kg/day, p.o.]). Rats were also administered with testosterone (in above mentioned dose) and finasteride 
RNA isolation and reverse transcription reaction
Total RNA isolation was carried out using TriPure Isolation Reagent (Roche Applied Science, Germany) according to the manufacturer's protocol. The RNA pellet was washed with 70% ethanol and dissolved in DEPC water. The integrity of RNA was visually assessed by conventional agarose gel electrophoresis and the concentration was measured by a measuring the absorbance at 260 and 280 nm in a spectrophotometer (BioPhotometer Eppendorf). RNA samples were stored at -80°C until used. The 1 µg of total RNA from all samples was reverse-transcribed into cDNA using Transcriptor cDNA First Strand Synthesis Kit (Roche, Germany) and oligo(dT)20 primer (Roche, Germany) according to manufacturer's protocol. Obtained cDNA samples were stored at -20°C or used directly for the quantitative real-time PCR (qRT-PCR) reaction.
Real time PCR assay
The genes expression level was analyzed by real-time quantitative PCR reaction using a LightCycler TM Instrument (Roche Applied Science, Germany) and a LightCycler Fast Start DNA Master SYBR Green I kit (Roche Applied Science, Germany) according to the instructions of the manufacturer. All primers sequences were designed using the Oligo 6.0 software (National Biosciences, USA), based on the sequence entries in the Genbank and synthesized from TIB Molbiol (TIB Molbiol Sp. z o.o., Poland). Primers sequences and specific PCR reaction conditions used for 5Ra5ar2, MaPK3, and a reference gene -GAPDH expression measurement are described in a table 1 (tab. 1). Primer specificity was verified by the assessment of a single PCR product on agarose gel and single temperature dissociation peak (melting curve analysis) of GAPDH cDNA amplification product was used as a housekeeping gene (endogenous internal standard) for normalization. The relative quantification for any given gene was expressed as a signal relative to the average signal value for the internal standard. A qRT-PCR reaction was carried out using a SYBR Green I in a reaction volume of 10 µl reaction mixture. Standard curves were prepared from dilution of cDNA and generated from a minimum of four data points. Complementary DNA was quantified by comparison of the number of cycles required for amplification of unknown samples with those of series of cDNA standard dilutions. All quantitative PCR reactions were repeated twice. The data were evaluated using LightCycler Run 5.32 software (Roche Applied Science, Germany). MAPK3R GATTTGGTGTAGCCCTTGGA All primers were designed using the Oligo 6.0 software (National Biosciences). F -forward primer R -reverse primer
Statistical analysis
The results were expressed as means ±SEM. Statistical significance of the difference between the control and experimental group was assessed by SPSS 17.0 (IBM Corporation, USA) software using one-way ANOVA test and Fischer LSD posthoc test. The values of p<0.05 were considered as statistically significant differences.
RESuLTS
Influence of Epilobium angustifolium extract on prostates weights in rats
It was shown that the testosterone induction caused the largest increase of rat prostates weight (induction over 100%) (p>0.05), while the administration with the E. angustifolium extract caused a statistically insignificant 19.5% decrease of prostate weights (p<0.05), as compared to control group, respectively. In testosterone-induced rats the presence of the studied extract did not affect prostate weights (a reduction of only ca. 4% was observed) (p<0.05), in comparison to control testosterone-induced rats. In animals administered with the testosterone and finasteride also there was no significant reduction in prostates weight (a decrease by 8% vs. testosterone administered rats) (p<0.05). The administration of finasteride-tested plant extract in animals injected with testosterone-induced the rise in prostate weights by ca. 25%, in comparison to the only testosterone-induced rats (p<0.05). Influence of Epilobium angustifolium extract on 5α-steroid reductase type 2 mRNA expression in rat prostate ventral lobe
In rats receiving Epilobium angustifolium extract a statistically insignificant strong induction (over 41-fold) of the 5α-steroid reductase type 2 mRNA (SRd5ar2) transcription was observed, in comparison to the control group (p>0,05). The highest induction of SRd5ar2 mRNA expression was observed in testosterone-induced rats -over 1244-fold vs. the control group (p<0.05). Also in animals administered both with testosterone and studied extract, a decrease of SRd5ar2 mRNA level (by ca. 88%) was observed, in comparison to testosterone-only induced rats (control) (p<0.05). The inhibitory effect of E. angustifolium extract was more potent than inhibition of SRd5ar2 mRNA transcription observed in testosterone-induced rats receiving finasteride (reduction ca. 61%) (p<0.05). Surprisingly, the administration with E. angustifolium extract and finasteride in testoterone induced rats caused a similar reduction (by ca. 81%) of the mRNA transcription, when compared to rats injected with testosterone (p<0.05). The differences of the mRNA level in each analyzed group were presented in a figure 2.
Influence of Epilobium angustifolium extract on 5α-reductase and MAPK3 kinase gene expression in rats prostates Vol. 59 No. 4 2013 administered animals; TFE -testosterone with E. angustifolium and finasteride administered animals; Data were presented as mean ±SEM in each group. *p<0.05 as compared with th control group (one-way ANOVA test)
Changes in mRNA expression level of 5α-steroid reductase type 2 (5ar2) in the ventral lobe of rat prostates influenced with Epilobium angustifolium extract. K -control group; E -animals administered with E. angustifolium extract; T -testosterone administered animals; TE -testosterone + E. angustifolium administered rats; TF -testosterone with finasteride administered animals; TFE -testosterone with E. angustifolium and finasteride administered animals; Data were presented as mean ±SEM in each group. *p<0.05 as compared with th control group (one-way ANOVA test)
Influence of Epilobium angustifolium extract on MAPk3 mRNA expression in rat prostate ventral lobes In our study, the level of MaPK3 mRNA in animals administered with testosterone and E. angustifolium extract strongly increased -over 18.5-fold and 4.6-fold, respectively (p<0.05), in comparison to control animals. The presence of finasteride in testosterone-induced animals caused a decrease of MaPK3 mRNA level by 37%, in comparison to rats receiving testosterone (control) (p<0.05). Surprisingly, the mRNA level increased (by 20%) in testosterone-induced rats administered with studied extract (p<0.05). In animals administered with testosterone the strongest induction of MaPK3 mRNA transcription was observed in rats receiving concomitantly E. angustifolium extract and finasteride (induction by ca. 71%), in comparison to rats receiving testosterone (p<0.05). The differences of the mRNA level in each analyzed group were presented in a figure 3.
presented as mean ±SEM in each group. *p<0.05 as compared to control group (one-way ANOVA test) K -control group; E -animals administered with E. angustifolium extract; T -testosterone administered animals; TE -testosterone + E. angustifolium administered rats; TF -testosterone with finasteride administered animals; TFEtestosterone with E. angustifolium and finasteride administered animals. Data were presented as mean ±SEM in each group. *p<0.05 as compared to control group (one-way ANOVA test)
DISCuSSION
Our results confirmed the androgen-dependent nature of transcriptional machinery regulating the mRNA synthesis of studied genes, which can be seen in particular in the group of testosterone-induced rats. In general, for all two tested genes (5α-reductase type 2 (SRd5ar2) and MaPK3 kinase), an induction of studied mRNA transcription in the ventral lobe of the prostate vs. the control animals was observed [ fig. 2, 3] . Changes in maintaining the ability of prostate cells to proliferate under the influence of the Epilobium sp. extracts were conducted mainly in in vitro model [9, 13, [17] [18] [19] [39] [40] . Only several studies have shown the inhibition of the activity of 5α-steroid reductase under the influence of various extracts or fractions of Epilobium sp. [24] [25] .
From our point of view, it is not clear why finasteride in rats administered with testosterone (an experimental induction of prostate growth) caused a smaller decrease in the level of mRNA 5α-steroid reductase 2 (by ca. 61%), than in rats treated with the hormone and studied plant extract (reduction by ca 88%), as compared to the control rats administered only with this androgen (p<0.05). It is well known that finasteride is a weakly competitive, reversible inhibitor of 5α-steroid reductase type 1 (SRd5aR1) and a potent, time-dependent inhibitor of type 2 protein (Srd5aR2) [41] [42] . Although there have been recent advances in developing of mechanistic models of the 5α-steroid reductase inhibition by finasteride and subsequent effects on the prostate [43] [44] [45] , the impact of this azasteroid on this enzyme transcription regulation is still the subject of the research. On the basis of literature data, we assume that in the case of E. angustifolium extract tannins, in particular, oenothein B and/or A may be responsible for these observed activities [15, 19, [24] [25] . It is possible that other bioactive compounds of this plant, like flavonoids and their derivatives, phytosterols and their derivatives as well as free fatty acids (mainly stearic, palmitic, oleic, linoleic, linolenic, and caproic) may cause the inhibition of 5α-steroid reductase 2 mRNA transcription [11, [24] [25] .
As already has been mentioned one of the key representatives of the AR mediated xenobiotics nongenomic signaling pathway are ERK1/2 kinases [28] . In the Rattus norvegicus analogues of human kinases ERK1/2 are MaPK3 and MaPK1, respectively. The analysis of literature data (Pubmed and Medline databases) has not revealed to us the already published experimental results that may indicate the cause of the impact of studied plant extract on the MaPK3 gene expression. It is therefore difficult, in our opinion, to clearly explain the general increase in the amount of MaPK3 transcripts (by a 20%) in testosterone-induced rats receiving E. angustifolium extracts, compared with testosterone treated animals) [ Fig. 3 ]. In our point of view that effect can also be explained with the differential influence of various bio-active substances, contained in the extract, on studied mRNA/or on the protein machinery regulating synthesis of these transcripts, which molecular background of interactions is still an issue that needs further research. The results obtained by our team in this subject are the first ever published.
It was shown that E. angustifolium extract at tested dose showed only a slight tendency to reduce prostate weight in testosterone-induced rats (p>0.05), as well as in rats administered concomitantly with testosterone and finasteride (p<0.05) ( fig. 1 ). In our opinion, it is possible that the strengthening of E. angustifolium extract inhibitory effect by finasteride may be due to a potential synergistic interaction between present in this herbal substance bio-active metabolites belonging to the fraction of flavonoids and/or tannins. The explanation of such relationships requires further studies.
CONCLuSIONS
In our experimental model, a statistically insignificant slight tendency to reduce prostate weights in hormonally induced animals by the E. angustifolium extract (p>0.05) and in testosterone-induced animals receiving both, extract and finasteride (p<0.05) is observed. A weak inhibition of 5α-steroid reductase 2 (Srd5ar2) mRNA synthesis in rats induced by testosterone treated finasteride. Proportionally inverse relationship between SRd5ar2 and MaPK3 mRNA expression profile of in both testosterone-induced groups of animals, receiving E. angustifolium extract with or without finasteride may occur due to the presence of the exogenous testosterone used in this study and potential interactions between bioactive metabolites present in this extract and testosterone or finasteride. The evaluation of efficacy and safety of studied plant extract in the prevention and symptomatic treatment of BPH requires further studies.
